-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$5.00145.1% Upside
BioAtla, Inc. Frequently Asked Questions
-
What analysts cover BioAtla, Inc.?
BioAtla, Inc. has been rated by research analysts at JMP Securities in the past 90 days.